MYC and non-small cell lung carcinoma: Mutations in proto-oncogenes and suppressor genes (e.g. p53, KRAS, Rb and myc genes) or abnormal promoter methylation belong to molecular mechanisms of malignant transformation and are detected in numerous cancers including non-small cell lung cancer (NSCLC) (Subramaniam et al. 2013).